newsfilter
← Latest News
Business Wire·

Lineage Initiates Clinical Study of OPC1 for Spinal Cord Injury

Safety Study of Stem Cell-derived Transplant Includes Subacute and Chronic SCI Patients Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell